multiple iv infusions hfes 2012 symposium proceedings …
TRANSCRIPT
2012 Symposium on Human Factors and Ergonomics in Health Care
MITIGATING RISKS ASSOCIATED WITH ADMINISTERING MULTIPLE INTRAVENOUS INFUSIONS: METHODS FOR ORGANIZING AND ANALYZING PROACTIVE RISK DATA
Andrea Cassano-Piché, M.A.Sc, P.Eng
Human Factors Engineer, Health Technology Safety Research Team University Health Network
Mark Fan, M.H.Sc
Human Factors Analyst, Health Technology Safety Research Team University Health Network
Anthony C. Easty, Ph.D, P.Eng, CCE
Health Technology Safety Research Team Leader University Health Network
Administering multiple infusions to a single patient is a requisite but risk-prone task that takes place in many patient care areas. Identifying and prioritizing the associated risks proactively requires detailed knowledge about the context, including a wide range of medication administration tasks and processes, which results in a large, highly interconnected data set. This paper discusses the methods used to collect, organize and analyze risk data related to the administration of multiple infusions in 12 patient care areas across 10 different hospitals, as well as the patient safety risk themes and associated hospital-based recommendations identified through this research.
Introduction A major challenge of collecting and analyzing proactive risk data using ethnography in the healthcare setting is the volume and complexity of the data that arises from the number of degrees of freedom in the system (Savage, 2000). Unlike other complex socio-technical safety-critical systems where the physical components and monitoring sensors of the system being controlled by expert users are fixed, and are defined primarily by physical principles (e.g., nuclear power plants), healthcare workers are often required dynamically to construct the physical systems they control and monitor as they are caring for patients. This increases the amount of context-specific data that must be captured and also increases the difficulty of separating out requisite from extraneous complexity. Administering multiple IV infusions to a single patient is a complex task with considerable patient safety risk (Cassano-Piché, Fan, Sabovitch, Masino, & Easty, 2012). It is, however, a requisite task for many nurses caring for patients receiving complex treatment and has not been systematically evaluated in terms of the types of associated risks and the effectiveness of potential mitigating strategies (Health Technology Safety Research Team, Institue for Safe Medication Practices Canada, 2010). It thus warrants a detailed proactive risk analysis to mitigate potential patient safety risks. This paper describes a research approach used to systematically collect and analyze a large, ethnographic field data set to support a proactive risk assessment of failure modes associated with administering multiple IV infusions to a single patient. It also presents the themes of issues identified,
and the corresponding recommendations to hospitals for mitigating some of the identified issues.
Methods
Data Collection Twelve ethnographic field studies were conducted across 10 Ontario hospitals in a wide range of patient care settings where multiple infusions are frequently administered to a single patient. Units included critical care environments, an emergency department, an inpatient oncology setting, and an outpatient oncology clinic. Four of the 10 field studies were conducted in pediatric settings and the remaining were conducted in adult care environments. A mixed methods approach was followed at each field study, which consisted of semi-structured interviews and direct observations of nurses caring for patients receiving multiple IV infusions. Each field study began with a semi-structured group interview of unit clinical administrators (e.g., nurse and pharmacy managers), clinical educators, medication prescribers, and risk managers. The number and type of participants varied across sites based on availability. Each interview lasted 2-3 hours and focused on the unit structure, infusion technologies in use, medication administration policies and practices, training and education, and challenges and safety issues related to administering multiple infusions. The interviews were followed by 2.5 days of direct observations conducted by two or three human factors researchers with experience in the healthcare domain. A nurse consultant on the project also participated in three of the field studies to further support the human factors researchers in understanding the clinical context.
Cop
yrig
ht 2
012
Hum
an F
acto
rs a
nd E
rgon
omic
s S
ocie
ty. A
ll rig
hts
rese
rved
. 10.
1518
/HC
S-2
012.
9452
8940
1.00
6
35
2012 Symposium on Human Factors and Ergonomics in Health Care
Qualitative field study data were collected in the form of photographs (Figures 1-2) and written notes. Issues within each field study were identified and tracked in a spreadsheet.
Figure 1. Multiple IV infusions connected to a single IV line via manifolds
Figure 2. IV tubing intertwined between the pump and the patient
Data Analysis The field study data set was large, and presented a challenge in terms of how to record the data such that the complex
cause-consequence relationships between issues both within and across field studies was preserved. The first attempt at managing the complexity of the data was to group the issues into task-based themes (Table 1). The themes provided a useful framework for dividing up the problem space so that individual researchers could explore each theme independently and concurrently, but did not make explicit how contributing factors across the system influenced problems in multiple themes. Table 1. Themes of issues identified from the field study data
Themes of Issues Secondary Infusions Line Set-up/Removal Line Identification Dead Volume Management IV Bolus Administration
To this end, the data were mapped onto a structural hierarchy representing the actions and decisions at all levels of the system (Figure 3). This type of structural hierarchy is a tool of Rasmussen’s 1997 Proactive Risk Management Framework (Rasmussen, 2007; Rasmussen & Svedung, 2000). Each element on the hierarchy (i.e., box) represented a potential contributing factor to a patient safety issue related to administering multiple IV infusions. The cause-consequence relationship between the factors was made explicit by a line connection creating chains of elements that sequentially led to outcomes that cause patient harm. Decisions and actions most directly connected to these outcomes were identified as primary issues. A risk analysis of the primary issues was conducted using a Healthcare Failure Modes and Effects Analysis (De Rosier, Stalhandske, Bagian, & Nudell, 2002). The HFMEA rating scheme is shown in Table 2. The cause-consequence chains associated with the critical issues were analyzed to identify potential mitigating strategies.
Results More than 100 field study data elements were mapped onto the structural hierarchy. Factors with the potential to contribute to patient harm were identified across all levels of the system. Twenty-two primary issues were identified, of which 17 were identified as critical issues based on the HFMEA risk analysis. Critical issues were defined as primary issues with a hazard score great than 24. Mitigating strategies were identified for several of the critical issues, which included at least one mitigating strategy for each theme except dead volume. Mitigations focused on interventions that could be implemented at the hospital or hospital-unit level of the system. The mitigating strategies were communicated as nine recommendations to hospitals and are presented in Table 3 and described fully in Cassano-Piché, Fan, Sabovich et al, 2012.
36
2012 Symposium on Human Factors and Ergonomics in Health Care
Table 2. Healthcare Failure Modes and Effects Analysis Rating Scheme for Multiple IV Infusion Issues Rating Detectability
1 No checking process is required to help detect the error. 2 A checking process is required to help detect the error,
but this process is not well defined and relies on human vigilance.
3 The error is not detectable based on current standards for knowledge/experience.
4 The error cannot be detected by any reasonable human process.
Rating Likelihood 1 Remote = the error may happen within the next 5 years 2 Uncommon = the error is likely to happen within the next
2–5 years 3 Occasional = the error is likely to happen within the next
1–2 years 4 Frequent = the error is likely to happen within the next
year Rating Severity
1 Minor = Error results in no harm, or the potential harm is unknown.
2 Moderate = Patient is temporarily harmed by the error. 3 Severe = Patient is permanently harmed by the error. 4 Critical = The error causes the patient’s death.
Table 3. Recommendations to hospitals based on an analysis of the structural hierarchy
Recommendation 1 When initiating a secondary medication infusion (often
referred to as a “piggyback” infusion), nurses should verify that the secondary infusion is active, and that the primary infusion is not active, by viewing the activity in both drip chambers. Full drip chambers should be partially emptied to restore the visibility of drips.
2 Continuous high-alert medications (Institute for Safe Medication Practices Canada, 2005) should be administered as primary infusions. Continuous high-alert medications should not be administered as secondary infusions.
3 Secondary infusions should be attached to primary infusion sets that have a back check valve. If infusion sets without back check valves are also available on the unit, multiple strategies should be employed to ensure that the types of tubing available are easily differentiated, and that the likelihood of a mix-up is minimized.
4 Hospitals should work towards the use of gowns that have snaps, ties, or Velcro on the shoulders and sleeves.
5 If an “emergency medication line” that is controlled by an infusion pump is set up on a patient, it is strongly suggested that the associated primary IV tubing be labelled as the emergency medication line at the injection port closest to the patient. The label should be prominent, and visually distinct from all other labels in the environment.
6 When setting up multiple IV infusions at the same time (e.g., a new patient requires many ordered infusions immediately, routine line changes), infusions should be set up one at a time, as completely as possible, before setting up the next infusion. Set-up tasks required for each infusion vary and may include:
• labelling (e.g., IV tubing, pump); • spiking and hanging the IV bag; • connecting the IV tubing to the pump; • programming the IV pump;
Organisation
Government
ProfessionalPractice
andTechnologyRegulators
Management
Staffand
PatientActivities
Equipmentand
surroundings
LabelsMed lines not
labeled (tubing)
LabelsMed lines
not labeled (pump)
LabelsDrug libraries do not display drug
name prominently or indicate access
information
LabelsExternal labels
applied to pumps to provide drug
name and access info
LabelsExternal pump labels not removed prior to
setting up a new infusion on the pump
LabelsDrug tubing labels wrapped around IV tubing leave part of
the drug name obscured
LabelsLabel placed on incorrect
drug tubing line
LabelsGeneric and brand name
used inconsistently across pump bag and drug tubing labels for a single patient (all 3 labels written and
applied by the same RN) see SRH
Labels-Illegible
handwriting on pump/drug tubing
labels-Poor visibility of
labels
LabelsInconsistent use of
colour to identify CVC lines across vendors
LabelsInconsistent use of terminology for drug abbreviations and
access locations on labels (between RNs
on same unit)
LabelsNo labels designed specifically for med line, drug tubing of
pump labeling in use
LabelsPatient access information on the pump label is inaccurate
LabelsPump/Drug
tubing labels fall off
LabelsNo drug
tubing labels applied to
lines
DRequired
medications not delivered to the patient
EDelay/
interruption in administration
of critical medications
AInfusion delivered at
incorrect rate
BIncompatible medications
running together
CVessicant medication
in PIV
PumpSingle interface used to program multiple
pump channels/modules
PumpSoftware/User
interfaceDesign issues
PumpHighly potent medications administered
concurrently via a pump with poor flow
rate accuracy
PumpDrug library/dose
calculator not used to program a
primary infusion
PumpPrimary infusion
programming error (wrong values
entered)
Line DiagnosisTransporting/ambulating
patients tangles the
lines
Line DiagnosisTubing
intertwined like spaghetti
Line DiagnosisNo standardized approach to line
setups (arrangement, components used, etc)
Line DiagnosisNo policies or best practice outlined for how to exchange IV
setup information during handover
Line DiagnosisLine setup information
not formally communicated at
handover
Line DiagnosisLine tracing
process prone to error
Line DiagnosisSlower running line
attached upstream of faster running line(s) and no chaser/driver
attached
Line Diagnosis
Line identified incorrectly
Line DiagnosisIV Bags do not physically align with the pumps
they are attached to
Line DiagnosisMedication connected
to/disconnect from incorrect line
Line DiagnosisIncorrect line
removed
Line DiagnosisSettings changed on
the wrong pump/channel
Dead VolumeSignificant change in rate of one or more of the fluids connected to other rate-critical medications
Line change required
Dead VolumeCVP line flushed
Dead VolumeMedications in dead volume of new tubing not in correct proportions for
undermined length of time
Dead VolumeOne or more rate-critical
medications (fluids) connected with other (fluids) medications into a single piece of tubing
Dead VolumeRate-critical medication
administered via CVP line
Inadequate training on managing multiple IV infusions
High risk medication delivered
Patient is receiving multiple
concurrent IV infusions
Lack of guidance given to nursing education programs
and hospitals about multiple IV infusion concepts required in
the curriculum/training program
IV medications not D/C when
other administration routes become
available
RNs work at more than one organization
SecondarySecondary tubing
connected to the incorrect port along the tubing (ie
downstream of pump instead of upstream)
SecondarySecondary clamp not unclamped
SecondarySecondary IV
bag connected to incorrect primary line
SecondaryLack of experience
setting up secondary infusions
SecondarySecondary infusions perceived as low risk
SecondaryLength of time to program via
drug library
SecondarySecondary infusion not programmed via
the drug library
SecondaryNo drug library available for secondary infusions (SMH/
Colleague)SecondaryNo bolus
appropriate profiles in the drug library
SecondaryBag height difference
not great enough
SecondaryTraditional pump used
SecondarySecondary infusion programming error
SecondaryPump software design prevents the use of the secondary mode if the
primary line is programmed using a drug library/drug
dose calculator(Graseby, Baxter...?)
SecondaryNo bolus
feature on the pump
SecondaryBolus of primary infusion given via secondary mode
SetupMultiple IV infusions connected
at the same time
SetupIV bag-pump mismatch (pump
programmed before bag connected)
SetupIV bag-programming mismatch (pump programmed after bag
connected) SetupPatient
transfers from one unit to another (or from EMS)
SetupPump label-bag
mismatch (label applied after bag attached + pump programmed)
SetupNurses try to space the IV bags
apart to make the bag labels more visible
SetupColleague pumps tubing needs
to be moved up over time
SetupTubing too short to reach between bag and pumps when
multiple pumps are stacked vertically
SetupSecondary hangers used to lower primary bags when no secondary infusion is running
Setup3-way stopcock product design
issue
SetupUse of recalled 3-way large bore stopcock to
connect multiple IV lines
SetupLimited
central IV access
SetupConnecting multiple stopcocks in series
results in leaks
SetupIVs need to be
rearranged prior to patients going for CT imaging (ie free up a
PIV line)
SetupBatch process of steps during setup of multiple IV infusions
Patient Harm
!"#
!"#$
%
$%
$%
$%
$%
$%
$%
$%
$%
$%
$%
!"#
$%
!"#
!"#
!"#
$%
$%
!"#
!"#
!"#
$%
SecondaryNo backcheck valve
on primary tubing
Line DiagnosisIV hooks arranged
circularly on IV poles
SetupBackflow can
occur through Y connectors for 2 primary lines if
pressure differential too high
Line DiagnosisIncubator and
crib sides impede the continuous
tracing of lines
Line DiagnosisOnly single
channel pumps used, requiring
stacking of pumps
LabelsPre-printed, colour-coded drug name stickers are only
available for some drugs
LabelsColour-code scheme for drug tubing labels
has many similar colours for different
drugs
LabelsSyringe labels
applied lengthwise are obscured by the syringe clip
Dead VolumeNo standard means of
communicating that a fluid should not be bolused
because it is connected to other medications with sensitive infusion rates $
%
Line DiagnosisMultiple drugs
have same opaque colour
(propofol, lipids, breaskmilk, NG
feeds)
Line DiagnosisSecondary medication injected into incorrect
line (tubing or buretrol) (pediatrics)
Dead VolumeNo standard process for
managing the dead volume of a 2 or 3-way y-style connector if a drug is discontinued and removed
FBolus of
incorrect fluid/medication
administered
Dead VolumeMedication unhooked
from 2 or 3-way y-style connector and
there residual volume in the line is not
identifyable
SecondarySome hangers not
long enough for longer IV bags
SecondarySecondary
medication not in drug library
SetupRN height/
reach
A
!"#
SecondaryUnnecessary port on primary tubing
just below the pump
SetupSequential
intermittent infusions hung in advance of being connected to
the pump
SetupWrong IV bag connected to
the pump
SetupPumps need
to be returned to home unit
SetupLack of
standard drug concentrations between units
SetupDrug library
not configured for the unit patient is
transferring to
SetupDifferent
pumps used on different
units
SetupConcentration
of drugs is different
between the units
SetupDate of IV line (based on policy)
SetupIV tubing/
connectors not compatible
with new unit
1
3
45
6
7 8
9
10
11
12
13
14
15
16 17
18
19
21 22
23
24
25
26
27
28
29
30
31
32
34
35
36
37
38
39
4041
42 43
44
45
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
73
74
75
76
77
78
79
80
81
83
84
85
86 87 88 89 90 91
92
93
94
96 97
98
99
100
101
102
103
104
105
SecondaryBack flow of
secondary infusion into primary infusion
113
106
Line DiagnosisLine tracing
prcess lengthy
108
GAdministration
of a discontinued medication
98
E
!"#
!"#
9
51
106
A
107
111
Drug library not configured optimally
110
65
Procurement selection not
optimal for clinical needs
105
86
61
59
112
18
22
43
49 112
114
Hospital Budget constraints
Lack of usability standards by
device regulators (Canada)
61
109
Dead VolumeIV connector design
results in dead volume
114
35
11
1214 23 18 68
99
Figure 3. Structural Hierarchy of Factors Contributing the Multiple IV Infusion Administration Risks
37
2012 Symposium on Human Factors and Ergonomics in Health Care
• connecting the IV tubing to the appropriate location (e.g., patient access, manifold); and
• starting the pump (unless a secondary infusion must be set up prior to starting the pump, or other infusions need to be connected to a multi-port connector before flushing).
Minor modifications to this recommendation are required for routine line changes.
7 Multiple 3-way stopcocks joined together in series to connect multiple IV infusions into a single line are prone to leaks, which may often be undetectable. Hospitals should provide multi-port or multi-lead connectors, and nurses should use these connectors to join multiple IV infusions into a single line, as required.
8 Hospitals should develop a policy to limit the practice of manually increasing the infusion rate to administer a medication bolus of a primary continuous infusion. If a medication bolus is to be administered using the primary continuous infusion pump/pump channel, then the nurse should program the bolus dose parameters (i.e., total amount of medication to be given over a defined duration) into the pump without changing any of the primary infusion parameters. Some examples may include the following:
• programming a bolus using a dedicated bolus feature in the pump
• programming a bolus using the pump’s secondary feature
9 Hospitals should ensure that their smart pump drug libraries include hard upper limits for as many high-alert medications as are appropriate for each clinical area, in order to prevent the administration of a bolus by manually increasing the primary flow rate.
Discussion The human factors proactive risk analysis of the processes associated with administering multiple IV infusions revealed that multiple IV infusion administration is a complex, risk-prone process that requires a systems approach to risk mitigation. The structural hierarchy tool from Rasmussen’s risk management framework (Rasmussen & Svedung, 2000) proved useful for organizing complex healthcare field study data, such that the relationship between many factors that influence human performance across levels of the system was explicit. This has several important implications for how risk-mitigating strategies are developed.
1. It supports a systematic analysis of the effect of a potential risk-mitigating strategy on all other elements of the system by making the relationship between all the elements explicit. This helps to minimize unintended negative consequences associated with changes to the system.
2. It supports a focus on solutions at higher levels of the system (e.g., government, regulatory bodies) than are usually considered, because the structural hierarchy tool prompts an inclusion of contributing factors at these levels.
3. It facilitates the aggregation of information across field sites, making the analysis more generalizable across the healthcare domain. Individual healthcare
organizations can each identify their own unique sub-set of issues from the set of factors presented on the hierarchy to create their own individual structural hierarchy as a first step towards developing mitigating strategies most important to their organization.
The nine recommendations identified in this study focused on the lower levels of the hierarchy, where human factors recommendations are traditionally made, because these recommendations can be immediately implemented to minimize risks. Mitigating strategies aimed at higher levels of the system (e.g., changes to clinical education programs, new standards for infusion systems) and solution approaches that require further study prior to determining the best mitigation approach are currently being investigated in the next phase of the study.
References 1. Cassano-Piché, A., Fan, M., Sabovich, S., Masino, C., &
Easty, A. C. (In Press). Multiple Intravenous Infusions Phase 1b: Practice and training scan. Ont Health Technol Assess Ser [Internet] . Toronto, ON, Canada
2. De Rosier, J., Stalhandske, E., Bagian, J. P., & Nudell, T. (2002). Using Health Care Failure Mode and Effects Analysis: The VA National Centre for Patient Safety's prospective risk analysis sistem. Joint Commission Journal of Quality Improvement , 28 (5), 248-267.
3. Health Technology Safety Research Team, Institue for Safe Medication Practices Canada. (2010, 09 24). Multiple Intravenous Infusions Phase 1a: Situation Scan Summary Report. Retrieved 03 19, 2012, from Health Technology Safety Research Team Web site: http://www.ehealthinnovation.org/files/Multiple%20IV%20Infusions_Phase1a_SummaryReport.pdf.
4. Institute for Safe Medication Practices Canada. (2005, 02 1). Secondary Infusions Require "Primary" Attention. ISMP Canada Safety Bulletin , 5 (2), pp. 1-2. Available at: http://ismp-canada.org/download/safetyBulletins/ISMPCSB2005-02SecondaryInfusions.pdf.
5. Rasmussen, J. (2007). Risk management in a dynamic society: A modeling problem. Safety Science , 27, 183-213.
6. Rasmussen, J., & Svedung, I. (2000). Proactive risk management in a dynamic society. Karlstad, Sweden: Swedish Rescue Services Agency.
7. Savage, J. (2000). Ethnography and health care. BMJ , 321, 1400-1402.
Acknowledgements This research was commissioned by the Ontario Health Technology Advisory Committee, funded by Health Quality Ontario and conducted in collaboration with the Institute for Safe Medication Practices (ISMP) Canada. The authors wish to thank the members of the Multiple IV Infusions Expert Panel, the AAMI Multiple Line Management Working Group and the health care staff who supported and participated in the field studies.
38